US04963C2098
US04963C2098
AtriCure, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 2.84B EUR | 1.42B EUR | 1.44B EUR | 1.97B EUR |
Enterprise Value | 2.59B EUR | 1.33B EUR | 1.37B EUR | 1.88B EUR |
Valuation Multiples | ||||
Trailing P/E | 265.76x | 134.87x | -- | -- |
Forward P/E | 128.6x | -- | -- | -- |
Price to Sales | 4.98x | 2.5x | 2.62x | 4.79x |
Price to Book | 5.5x | 2.76x | 2.94x | 4x |
EV/Revenue | 4.55x | 2.33x | 2.48x | 4.56x |
EV/EBITDA | 76.88x | 34.38x | 58.91x | 115.4x |
Price to FCF (P/FCF) | 58.16x | 27.31x | 30.32x | 35.5x |
EV/FCF | 53.15x | 25.45x | 28.76x | 33.8x |
FCF Yield | 1.72% | 3.66% | 3.3% | 2.82% |